←Back to Expert Scholars
Translational Medicine / 转化医学Emerging Lung Targets
Julia Rotow
MD
🏢Dana-Farber Cancer Institute🌐USA
Clinical Director, Lowe Center for Thoracic Oncology
35
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Julia Rotow is a thoracic oncologist at Dana-Farber specializing in targeted therapy for EGFR and uncommon driver NSCLC. She has contributed to trials of amivantamab, HER3-DXd and next-generation TKIs. Her work emphasizes CNS-active therapy development for brain metastasis patients.
Share:
🧪Research Fields 研究领域
EGFR-mutant NSCLC
HER3 ADCs
Resistance mechanisms
Brain metastases
Clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Julia Rotow 的研究动态
Follow Julia Rotow's research updates
留下邮箱，当我们发布与 Julia Rotow（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment